Diaceutics Plc (DXRX) Ord GBP0.002
0.50p
(0.40%)
- Add to watchlist
- Create an alert
- This stock can be held in a
0.50p
(0.40%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
0.50p
(0.40%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
126.50p
130.00p
151.00p
£106.07 million
125.00p
125.41p
95.00p
n/a
1.50p (1.19%) Previous:
1.50p
25,222
n/a
3,000
Performance
Not available for this stock.
Fundamental data
| Year ending: | 31/12/2023 | 31/12/2022 |
|---|---|---|
| Revenue (£m) | 23.70 | 19.50 |
| Profit before tax (£m) | (2.44) | 0.56 |
| Adjusted EPS (p): | (2.07) | 0.86 |
| P/E ratio | n/a | 87.80 |
| PEG | n/a | 3.10 |
| EPS growth (%) | n/a | 28.00 |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
Diaceutics wins $5.1m contract with global pharma firm
17 December 2024 13:35
-
Diaceutics awarded £1m in UKRI funding
5 December 2024 13:23
-
Diaceutics reports progress in scaling US strategy
28 November 2024 10:28
-
Holding(s) in Company
6 March 2025 15:16
-
PDMR Shareholding/Share Incentive Plan and TVR
3 March 2025 15:00
-
Purchase of Shares and PDMR Shareholding
31 January 2025 09:13
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.